NEW YORK (GenomeWeb News) – Genetic Technologies announced today it is licensing patents related to its non-coding DNA technology to Conexio Genomics.

Financial and other terms of the non-exclusive deal were not disclosed.

Based in Fremantle, Western Australia, Conexio develop genetic sequencing and mutation detection products and provides services in those areas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.